Clinical Trials
4
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Analysis of Cataract Surgery Induced Dry Eye
- Conditions
- Cataract
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2016-02-04
- Lead Sponsor
- TearLab Corporation
- Target Recruit Count
- 61
- Registration Number
- NCT01471561
- Locations
- 🇺🇸
William Trattler, MD, Miami, Florida, United States
🇺🇸David Hardten, MD, Minneapolis, Minnesota, United States
🇺🇸Chris Starr, MD, New York, New York, United States
TearLab Refractive Surgery Dry Eye Study
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2016-02-04
- Lead Sponsor
- TearLab Corporation
- Target Recruit Count
- 128
- Registration Number
- NCT01176045
- Locations
- 🇺🇸
Connecticut TLC, Fairfield, Connecticut, United States
🇺🇸Westchester TLC, Westchester, Illinois, United States
🇺🇸Oklahoma City TLC, Oklahoma City, Oklahoma, United States
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
- Conditions
- Keratoconjunctivitis Sicca
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- TearLab Corporation
- Target Recruit Count
- 314
- Registration Number
- NCT00848198
- Locations
- 🇺🇸
Gordon Binder Weiss Vision Institute, San Diego, California, United States
🇺🇸Kentucky Lion Eye Center, Louisville, Kentucky, United States
🇺🇸Pepose Vision Institute, Chesterfield, Missouri, United States
Validation of TearLab Osmometer - Human Factor Usability Report
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- TearLab Corporation
- Target Recruit Count
- 233
- Registration Number
- NCT00731484
- Locations
- 🇺🇸
Gordon Binder Weiss Vision Institute, San Diego, California, United States
🇺🇸Kentucky Lion Eye Center, University of Louisville, Louisville, Kentucky, United States
🇺🇸The Ohio State University College of Optometry, Columbus, Ohio, United States
